Skip to main content
. 2019 Jul 7;8(11):1126–1134. doi: 10.1002/sctm.19-0073

Table 2.

Distribution of preclinical mesenchymal stem cells (MSC) studies in inflammatory diseases with a focus on sepsis, acute lung injury, acute respiratory distress syndrome, arthritis, and colitis, based on MSC preparation prior to administration (used straight from culture or after thawing) and corresponding efficacy

# of papers % Efficacy No efficacy
Not stated 66 71.7 61 5
Cultured 19 20.7 19 0
Thawed 5 5.4 5 0
Cultured vs. thawed 2 2.2 2 0
Total 92